Adjuvant early and late cardioprotective therapy: Access to the heart

Rabea Hinkel, Peter Boekstegers, Christian Kupatt

Publikation: Beitrag in FachzeitschriftÜbersichtsartikelBegutachtung

7 Zitate (Scopus)

Abstract

Coronary heart disease is still the leading cause of death in industrialized nations, occurring either as acute coronary occlusion and myocardial infarction or as chronic ischaemic cardiomyopathy caused by continuous obstruction of one or more coronary arteries. Even after successful reperfusion, an additional loss of otherwise vital cardiomyocytes may occur in the primary ischaemic area, called lethal reperfusion injury. In experimental settings, delivery of therapeutic agents targeting the reperfusion injury reduces the infarct size by 30. In addition to the choice of therapeutic agent and time point, the mode of application may be crucial for the therapeutic success. Therefore, this review focuses on the current and future administration techniques for early and late post-myocardial infarction therapies.

OriginalspracheEnglisch
Seiten (von - bis)226-236
Seitenumfang11
FachzeitschriftCardiovascular Research
Jahrgang94
Ausgabenummer2
DOIs
PublikationsstatusVeröffentlicht - 1 Mai 2012
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Adjuvant early and late cardioprotective therapy: Access to the heart“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren